Balixafortide

• Description:

  A novel potent, selective, peptidic CXCR4 antagonist that interferes with the tumor-protective microenvironment and sensitizes tumor cells to chemotherapy.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  1782.029

• Molecular Formula:

  C80H112N22O21S2

• Notes:

  Research use only, not for human use.

• Receptor:

  Chemokine Receptor

• CAS Number:

  1051366-32-5